Matthew Coffey, President & Chief Executive Officer at Oncolytics Biotech, holds 96.33K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Matthew Coffey Bought $7,900 shares of Oncolytics Biotech on Jun 16, 2022 for an estimated value of 6.67K.
What is the percentage of profitable transactions made by Matthew Coffey?
The percentage of profitable transactions made by Matthew Coffey is 83%.
What is the average return per transaction made by Matthew Coffey?
The average return per transaction made by Matthew Coffey is 82.20%.
What stocks does Matthew Coffey hold?
Matthew Coffey holds: ONCY stocks.
What was Matthew Coffey’s latest transaction?
Matthew Coffey latest transaction was an Informative Buy of $6.67K.
What was Matthew Coffey's most profitable transaction?
Matthew Coffey’s most profitable transaction was an Informative Buy of ONCY stock on October 3, 2019. The return on the trade was 287.80%.
What is Matthew Coffey's role in Oncolytics Biotech?
Matthew Coffey's role in Oncolytics Biotech is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.